Tora S Solheim1, Barry J A Laird. 1. Department of Cancer Research and Molecular Medicine, European Palliative Care Research Centre, Norwegian University of Science and Technology, Trondheim, Norway. tora.l.skeidsvoll@ntnu.no
Abstract
PURPOSE OF REVIEW: The lack of success of unimodal treatment studies in cachexia and the growing awareness that multiple components are responsible for the development of cachexia have led to the view that cachexia intervention should include multimodal treatment. The aim of this article is to examine the evidence for multimodal treatment in the management of cancer cachexia. RECENT FINDINGS: There are some studies involving multimodal treatment that indicate significant effects on cachexia outcomes. There are, however, no randomized controlled trials to date that incorporate fully a structured exercise program, nutrition, good symptom treatment as well as drug treatment, to counteract the effects of altered metabolism. SUMMARY: The effectiveness of any drug intervention for cancer cachexia probably will only be maximized if incorporated into multimodal treatment. Further, cachexia treatment trials should also aim to include patients at an early phase in their cachexia trajectory and use validated outcome measures.
PURPOSE OF REVIEW: The lack of success of unimodal treatment studies in cachexia and the growing awareness that multiple components are responsible for the development of cachexia have led to the view that cachexia intervention should include multimodal treatment. The aim of this article is to examine the evidence for multimodal treatment in the management of cancer cachexia. RECENT FINDINGS: There are some studies involving multimodal treatment that indicate significant effects on cachexia outcomes. There are, however, no randomized controlled trials to date that incorporate fully a structured exercise program, nutrition, good symptom treatment as well as drug treatment, to counteract the effects of altered metabolism. SUMMARY: The effectiveness of any drug intervention for cancer cachexia probably will only be maximized if incorporated into multimodal treatment. Further, cachexia treatment trials should also aim to include patients at an early phase in their cachexia trajectory and use validated outcome measures.
Authors: Tim A Labeur; Jeroen L A van Vugt; David W G Ten Cate; R Bart Takkenberg; Jan N M IJzermans; Bas Groot Koerkamp; Robert A de Man; Otto M van Delden; Ferry A L M Eskens; Heinz-Josef Klümpen Journal: Liver Cancer Date: 2018-11-02 Impact factor: 11.740
Authors: Antonio Jose Grande; Valter Silva; Larissa Sawaris Neto; João Pedro Teixeira Basmage; Maria S Peccin; Matthew Maddocks Journal: Cochrane Database Syst Rev Date: 2021-03-18
Authors: Matthew Maddocks; Jane Hopkinson; John Conibear; Annie Reeves; Clare Shaw; Ken C H Fearon Journal: Curr Opin Support Palliat Care Date: 2016-12 Impact factor: 2.302
Authors: Louise E Daly; Éadaoin B Ní Bhuachalla; Derek G Power; Samantha J Cushen; Karl James; Aoife M Ryan Journal: J Cachexia Sarcopenia Muscle Date: 2018-01-09 Impact factor: 12.910
Authors: Mónica Patricia Cala; María Teresa Agulló-Ortuño; Elena Prieto-García; Carolina González-Riano; Lucía Parrilla-Rubio; Coral Barbas; Carmen Vanesa Díaz-García; Antonia García; Cristina Pernaut; Jorge Adeva; María Carmen Riesco; Francisco Javier Rupérez; Jose Antonio Lopez-Martin Journal: J Cachexia Sarcopenia Muscle Date: 2018-02-20 Impact factor: 12.910
Authors: Tora S Solheim; Barry J A Laird; Trude Rakel Balstad; Guro B Stene; Asta Bye; Neil Johns; Caroline H Pettersen; Marie Fallon; Peter Fayers; Kenneth Fearon; Stein Kaasa Journal: J Cachexia Sarcopenia Muscle Date: 2017-06-14 Impact factor: 12.910
Authors: Ola Magne Vagnildhaug; Cinzia Brunelli; Marianne J Hjermstad; Florian Strasser; Vickie Baracos; Andrew Wilcock; Maria Nabal; Stein Kaasa; Barry Laird; Tora S Solheim Journal: BMC Palliat Care Date: 2019-06-04 Impact factor: 3.234
Authors: Marie Fallon; Barry J Laird; Charlie C Hall; Lucy Norris; Liz Dixon; Jane Cook; Matthew Maddocks; Catriona Graham; Sharon Tuck; Erna Haraldsdottir; Duncan Brown; Anna Lloyd; Anne Finucane; Peter Hall; Katharina Diernberger; Richard J E Skipworth Journal: Pilot Feasibility Stud Date: 2018-12-27